CAS: 14852-31-4; 2-Hexadecanol

该化合物是一种具有分子式C16H34O的长链脂肪醇,其特征为直链结构,与六十二烷主干骨的第二碳相连,具有氢氧(-OH)基,该物质在室温中一般是无色的,蜡状的固体,在水中不溶解,但在有机溶剂中溶解. 2-Hexadecanol因其溶解性而闻名,在化妆品配方和个人护理产品中有用,也可以用作表面活性剂,用于润滑剂和塑料剂的生产.该物质的熔点和沸点相对高于短链酒精,反映其较大的分子规模.此外,该物质被认为毒性较低,但具体应用中应始终参考安全数据.

结构式图片

上下游产品

CAS号629-73-2 1-十六烯 | CAS号18787-63-8 2-十六烷酮 | CAS号88303-25-7 Bromotetradecyl... | CAS号75-07-0 乙醛 | CAS号544-76-3 正十六烷 | CAS号26741-29-7 hexadec-2-ene | CAS号629-73-2 1-十六烯 | CAS号18787-63-8 2-十六烷酮 | CAS号74036-96-7 2-bromohexadecane

合成工艺路线路线简述

    📜Alkaline Earth Salt Of/the/ Methylsulfuric Acid置于硫酸体系中,化学反应生成2-十六醇
    参考文献:Non-Organic Visual Loss In Children
    标题:Non-Organic Visual Loss In Children
    摘要:背景 非器质性视力丧失(novl)患者会占用大量的门诊时间,临床医生往往需要进行昂贵而漫长的检查以确保诊断正确.儿童的情况尤其如此.方法 回顾性审查了 30 名儿童(18 名女孩,12 名男孩)的病例记录,他们的主诉是视力受损,诊断为非器质性视力损失.这一数字占本单位儿科新转诊病例的 1%.相关症状包括头痛,眶周疼痛,复视,畏光和怕光.5 名患者出现视野缺损,1 名儿童出现近反射痉挛.结果 治疗包括安抚,所有病例的视功能均恢复正常.三名患儿被转诊至其他医疗机构.所有心理物理学,电生理学和神经放射学检查结果均为阴性.结论 我们的研究表明,非器质性视力丧失在青春期前儿童中较为常见,大多数病例可通过标准临床测试安全地诊断出来.及时诊断可避免不必要的检查和延长 "病程".同时存在的社会冲突很常见,可能也是诱因之一.向患儿和家长仔细解释并安抚他们的情绪仍然是治疗的主要方法.
    Doi:10.1038/eye.2000.201

    海关参考信息

    专利信息


    专利号:WO-2014108526-A1
    优先权日:2013-01-11
    标题 :Synthetic process for the manufacture of pipecolidepsin compounds
    发明人:PELAY GIMENO MARTA; GARCÃ?A-RAMOS YESICA; TULLA PUCHE JUDIT; ALBERICIO PALOMERA FERNANDO; MARTÃ?N LÓPEZ M JES S
    权利人:PHARMA MAR SA
    摘要:(I) wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , R 12 , n and Y are as described. The invention provides a process for the synthesis of complex pipecolidepsin and related compounds of formula (I), opening a new field of compounds with useful biological properties. The invention also provides intermediates, useful in the synthesis of compounds of formula (I).

    专利号:US-8178585-B2
    优先权日:2007-11-14
    标题 :Solvent-free synthesis of soluble nanocrystals
    发明人:PETRUSKA MELISSA; PAN GUIQUAN
    权利人:PETRUSKA MELISSA; PAN GUIQUAN; ADVANCED TECH MATERIALS
    摘要:Methods for preparing high quality and high yields of nanocrystals, i.e., metal-oxide-based nanocrystals, using a novel solvent-free method. The nanocrystals advantageously comprise organic alkyl chain capping groups and are stable in air and in nonpolar solvents.

    专利号:US-4517371-A
    优先权日:1981-12-02
    标题:Process for the synthesis of carboxylic anhydrides using a vanadium, phosphorus oxygen containing catalyst composition
    发明人:YANG TAI-CHENG; RAO KRISHNA K; HUANG I-DER
    权利人:EXXON RESEARCH ENGINEERING CO
    摘要:A vanadium, phosphorus oxygen containing catalyst composition capable of partially oxidizing hydrocarbons (e.g., n-butane) to form a carboxylic anhydride (e.g., maleic anhydride), a process for preparing this catalyst, and a process for using this catalyst to form such anhydrides is disclosed. The catalyst composition is prepared by an organic heterogenous technique followed by a water treatment step and activation.

    专利号:US-10017465-B2
    优先权日:2014-08-12
    标 题 :Method for producing astaxanthin from astacin
    发明人:Schäfer Bernd; SIEGEL WOLFGANG
    权利人:BASF SE
    摘要:The invention relates to a method for the non-stereoselective and also for the stereoselective synthesis of astaxanthin from astacin. For this purpose, a reducing agent is used selected from the group of hydrogen, a secondary alcohol, formic acid and also the salts of formic acid or from a mixture of at least two representatives of the compound classes stated above. The invention further relates to the use of astacin as starting compound for the synthesis of astaxanthin.

    专利号:CN-101403138-A
    优先权日:2008-10-29
    标题 :Synthesis of an Oxide Nanocrystal

    专利号:US-2011006269-A1
    优先权日:2007-11-14
    标题:Solvent-free synthesis of soluble nanocrystals

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知